Beauty Health Co (NASDAQ: SKIN) CRO receives 746,681 restricted stock units
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Menezes Ronald reported acquisition or exercise transactions in this Form 4 filing.
Beauty Health Co reported that Chief Revenue Officer Ronald Menezes received a large equity grant in the form of restricted stock units (RSUs). He was awarded 746,681 RSUs of Class A Common Stock at no purchase price as part of his compensation.
Each RSU represents a future right to receive one share of Class A Common Stock, subject to time-based vesting. The award vests in three equal installments on each of the first three anniversaries of the March 20, 2026 grant date, contingent on continued service and certain acceleration rights. Following this grant, Menezes directly owns 1,759,915 shares of the company’s Class A Common Stock.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Menezes Ronald
Role
Chief Revenue Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Class A Common Stock | 746,681 | $0.00 | -- |
Holdings After Transaction:
Class A Common Stock — 1,759,915 shares (Direct)
Footnotes (1)
- [object Object]
FAQ
What did Beauty Health Co (SKIN) disclose about Ronald Menezes in this Form 4?
Beauty Health Co reported that Chief Revenue Officer Ronald Menezes received a grant of 746,681 restricted stock units. These RSUs are a form of equity compensation and will convert into Class A Common Stock only as they vest over time, subject to continued service.
How many restricted stock units did SKIN’s Chief Revenue Officer receive?
Ronald Menezes received 746,681 restricted stock units of Beauty Health Co Class A Common Stock. Each RSU represents a contingent right to one share, with no cash paid per share, and will vest in stages over a three-year period starting from March 20, 2026.
What are the vesting terms of Ronald Menezes’ RSU grant at Beauty Health Co?
The RSUs vest in one-third increments on each of the first three anniversaries of March 20, 2026. Vesting is conditioned on Menezes’ continued service with Beauty Health Co through each vesting date, and the award is also subject to certain acceleration rights described in the grant terms.
Is Ronald Menezes’ RSU award a market purchase or a compensation grant from SKIN?
The transaction is a compensation-related grant, not a market purchase. The Form 4 shows transaction code “A” and a price of $0.00 per share, indicating a grant or award of RSUs provided by Beauty Health Co as part of his equity-based compensation package.
What type of security is involved in Ronald Menezes’ Form 4 for Beauty Health Co (SKIN)?
The filing involves Class A Common Stock of Beauty Health Co, delivered through restricted stock units. Each RSU represents a contingent right to receive one share of Class A Common Stock in the future, subject to time-based vesting and continued employment with the company.